NEW YORK--(BUSINESS WIRE)--Critical Diagnostics today announced that a pivotal research paper has been published in The Journal of the College of Cardiology (www.onlinejacc.org), titled, “Measurement of the Interleukin Family Member ST2 in Patients with Acute Dyspnea: Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.” The results of the study clearly demonstrate the strength of ST2 as a biomarker for risk stratification and prediction of mortality in patients who present to the emergency department with shortness of breath and suspected acute decompensated heart failure, according to lead researcher and author Dr. James L. Januzzi.
